“The American Lung Association is committed to helping those with lung cancer and their caregivers cope with the changes this disease brings. We’re proud to partner with Inspire to connect patients and their caregivers with support and resources during their journey,” explained Harold P. Wimmer, the CEO and President of the American Lung Association National.
The partnership will strengthen the Inspire American Lung Association Lung Cancer Survivors Community, which at over 40,000 members is already the largest, most active online group for individuals affected by lung cancer, in order to become a much stronger force in furthering medical progress and assisting lung cancer patients and their respective caregivers.
In the year 2014 alone, the members of the community shared over 125,000 posts with information, questions, and support by and for caregivers and patients.
In addition to this invaluable online assistance, the Lung Association will also join forces with Inspire to support those suffering from chronic obstructive pulmonary disease (COPD) and other lung conditions, thanks to the Inspire Living with COPD Support Community and the Inspire Living with Lung Disease Support Community.
“We are thrilled to team with the American Lung Association. The Lung Association is known and respected for providing resources for people affected by lung disease, and they’ll help Inspire accelerate medical progress in this crucial area,” added Brian Loew, Inspire CEO.
Read More Recent News
Researchers at The Valley Hospital recently announced that they are working on paving the way for a much easier, accurate and less invasive method to screen for the most frequent type of lung cancer. Lung cancer is a leading cancer killer in men and responsible for the most cancer deaths in the United States. The team found that detecting a protein found in the blood appears to be more precise than using low-dose CT scans, the current method used for detecting non-small cell lung cancer. This project complements the recent discovery of a biomarker for pancreatic cancer, which was begun six years ago at Valley.